Boulding Mark Elliott bought PTCT
February 17, 2026 · Form 4 insider transaction
Boulding Mark Elliott bought 2,813 shares of PTC Therapeutics, Inc. at $25.69 per share, a transaction worth $72.3K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,813
Price
$25.69
Total value
$72.3K
InsiderBoulding Mark Elliott
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateFebruary 17, 2026
Filing dateFebruary 19, 2026
Shares owned after114,125
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 4, 2024.